메뉴 건너뛰기




Volumn , Issue , 2012, Pages 211-234

Checkpoint Kinase and Wee1 Inhibitors as Anticancer Therapeutics

Author keywords

[No Author keywords available]

Indexed keywords


EID: 84882420043     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-384999-1.10010-1     Document Type: Chapter
Times cited : (8)

References (155)
  • 2
    • 3943107573 scopus 로고    scopus 로고
    • Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints
    • Sancar A., Lindsey-Boltz L.A., Unsal-Kacmaz K., Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Ann Rev Biochem 2004, 73:39-85.
    • (2004) Ann Rev Biochem , vol.73 , pp. 39-85
    • Sancar, A.1    Lindsey-Boltz, L.A.2    Unsal-Kacmaz, K.3    Linn, S.4
  • 3
    • 0034707047 scopus 로고    scopus 로고
    • The DNA damage response: putting checkpoints in perspective
    • Zhou B.B., Elledge S.J. The DNA damage response: putting checkpoints in perspective. Nature 2000, 408:433-439.
    • (2000) Nature , vol.408 , pp. 433-439
    • Zhou, B.B.1    Elledge, S.J.2
  • 4
    • 0029808466 scopus 로고    scopus 로고
    • Cell cycle checkpoints: preventing an identity crisis
    • Elledge S.J. Cell cycle checkpoints: preventing an identity crisis. Science 1996, 274:1664-1672.
    • (1996) Science , vol.274 , pp. 1664-1672
    • Elledge, S.J.1
  • 5
    • 33747830026 scopus 로고
    • Artificial transmutation of the gene
    • Muller H.J. Artificial transmutation of the gene. Science 1927, 66:84-87.
    • (1927) Science , vol.66 , pp. 84-87
    • Muller, H.J.1
  • 6
    • 84964160994 scopus 로고
    • Effect of sublethal doses of monochromatic ultraviolet radiation on bacteria in liquid suspensions
    • Hollaender A., Curtis J.T. Effect of sublethal doses of monochromatic ultraviolet radiation on bacteria in liquid suspensions. Proc Soc Exp Biol Med 1935, 33:61-62.
    • (1935) Proc Soc Exp Biol Med , vol.33 , pp. 61-62
    • Hollaender, A.1    Curtis, J.T.2
  • 7
    • 62349099494 scopus 로고
    • The effects of sublethal doses of monochromatic ultraviolet radiation on the growth properties of bacteria
    • Hollaender A., Duggar B.M. The effects of sublethal doses of monochromatic ultraviolet radiation on the growth properties of bacteria. J Bacteriol 1938, 36:17-37.
    • (1938) J Bacteriol , vol.36 , pp. 17-37
    • Hollaender, A.1    Duggar, B.M.2
  • 8
    • 70350504453 scopus 로고    scopus 로고
    • The DNA-damage response in human biology and disease
    • Jackson S.P., Bartek J. The DNA-damage response in human biology and disease. Nature 2009, 461:1071-1078.
    • (2009) Nature , vol.461 , pp. 1071-1078
    • Jackson, S.P.1    Bartek, J.2
  • 9
    • 63749131243 scopus 로고    scopus 로고
    • Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2
    • Reinhardt H.C., Yaffe M.B. Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2. Curr Opin Cell Biol 2009, 21:245-255.
    • (2009) Curr Opin Cell Biol , vol.21 , pp. 245-255
    • Reinhardt, H.C.1    Yaffe, M.B.2
  • 10
    • 58849146288 scopus 로고    scopus 로고
    • Distinct mechanisms act in concert to mediate cell cycle arrest
    • Toettcher J.E., Loewer A., Ostheimer G.J., et al. Distinct mechanisms act in concert to mediate cell cycle arrest. Proc Natl Acad Sci USA 2009, 106:785-790.
    • (2009) Proc Natl Acad Sci USA , vol.106 , pp. 785-790
    • Toettcher, J.E.1    Loewer, A.2    Ostheimer, G.J.3
  • 11
    • 2342459790 scopus 로고    scopus 로고
    • DNA damage-induced apoptosis
    • Norbury C.J., Zhivotovsky B. DNA damage-induced apoptosis. Oncogene 2004, 23:2797-2808.
    • (2004) Oncogene , vol.23 , pp. 2797-2808
    • Norbury, C.J.1    Zhivotovsky, B.2
  • 12
    • 67649595826 scopus 로고    scopus 로고
    • Apoptosis and cancer: The genesis of a research field
    • Cotter T.G. Apoptosis and cancer: The genesis of a research field. Nat Rev Cancer 2009, 9:501-507.
    • (2009) Nat Rev Cancer , vol.9 , pp. 501-507
    • Cotter, T.G.1
  • 13
    • 33646414521 scopus 로고    scopus 로고
    • ATR-Chk1 axis protects BCR/ABL leukemia cells from the lethal effect of DNA double-strand breaks
    • Nieborowska-Skorska M., Stoklosa T., Datta M., et al. ATR-Chk1 axis protects BCR/ABL leukemia cells from the lethal effect of DNA double-strand breaks. Cell Cycle 2006, 5:994-1000.
    • (2006) Cell Cycle , vol.5 , pp. 994-1000
    • Nieborowska-Skorska, M.1    Stoklosa, T.2    Datta, M.3
  • 14
    • 34447620928 scopus 로고    scopus 로고
    • Mechanism of G2/M blockage triggered by activated-Chk1 in regulation of drug-resistance in K562/A02 cell line
    • Wang H.Y., Zhang M., Zou P., et al. Mechanism of G2/M blockage triggered by activated-Chk1 in regulation of drug-resistance in K562/A02 cell line. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2006, 14:1105-1109.
    • (2006) Zhongguo Shi Yan Xue Ye Xue Za Zhi , vol.14 , pp. 1105-1109
    • Wang, H.Y.1    Zhang, M.2    Zou, P.3
  • 15
    • 33845317573 scopus 로고    scopus 로고
    • Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
    • Bao S., Wu Q., McLendon R.E., Hao Y., et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444:756-760.
    • (2006) Nature , vol.444 , pp. 756-760
    • Bao, S.1    Wu, Q.2    McLendon, R.E.3    Hao, Y.4
  • 16
    • 29244437908 scopus 로고    scopus 로고
    • The role of double-strand break repair: insights from human genetics
    • O'Driscoll M., Jeggo P.A. The role of double-strand break repair: insights from human genetics. Nat Rev Genet 2006, 7:45-54.
    • (2006) Nat Rev Genet , vol.7 , pp. 45-54
    • O'Driscoll, M.1    Jeggo, P.A.2
  • 17
    • 33646183367 scopus 로고    scopus 로고
    • DNA damage responses and their many interactions with the replication fork
    • Andreassen P., Ho G., D'Andrea A. DNA damage responses and their many interactions with the replication fork. Carcinogenesis 2006, 27:883-892.
    • (2006) Carcinogenesis , vol.27 , pp. 883-892
    • Andreassen, P.1    Ho, G.2    D'Andrea, A.3
  • 18
    • 1542725073 scopus 로고    scopus 로고
    • Targeting the checkpoint kinases: chemosensitization versus chemoprotection
    • Zhou B.B., Bartek J. Targeting the checkpoint kinases: chemosensitization versus chemoprotection. Nat Rev Cancer 2004, 4:216-225.
    • (2004) Nat Rev Cancer , vol.4 , pp. 216-225
    • Zhou, B.B.1    Bartek, J.2
  • 19
    • 0642286492 scopus 로고    scopus 로고
    • Drug discovery targeting Chk1 and Chk2 kinases
    • Zhou B.B., Sausville E.A. Drug discovery targeting Chk1 and Chk2 kinases. Prog Cell Cycle Res 2003, 5:413-421.
    • (2003) Prog Cell Cycle Res , vol.5 , pp. 413-421
    • Zhou, B.B.1    Sausville, E.A.2
  • 20
    • 0035545996 scopus 로고    scopus 로고
    • Mammalian G1- and S-phase checkpoints in response to DNA damage
    • Bartek J., Lukas J. Mammalian G1- and S-phase checkpoints in response to DNA damage. Curr Opin Cell Biol 2001, 13:738-747.
    • (2001) Curr Opin Cell Biol , vol.13 , pp. 738-747
    • Bartek, J.1    Lukas, J.2
  • 22
    • 0012966157 scopus 로고    scopus 로고
    • Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A
    • Sorensen C.S., Syljuasen R.G., Falck J., et al. Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A. Cancer Cell 2003, 3:247-258.
    • (2003) Cancer Cell , vol.3 , pp. 247-258
    • Sorensen, C.S.1    Syljuasen, R.G.2    Falck, J.3
  • 23
    • 0034717309 scopus 로고    scopus 로고
    • Rapid destruction of human Cdc25A in response to DNA damage
    • Mailand N., Falck J., Lukas C., et al. Rapid destruction of human Cdc25A in response to DNA damage. Science 2000, 288:1425-1429.
    • (2000) Science , vol.288 , pp. 1425-1429
    • Mailand, N.1    Falck, J.2    Lukas, C.3
  • 24
    • 0036847320 scopus 로고    scopus 로고
    • Regulation of G(2)/M events by Cdc25A through phosphorylation-dependent modulation of its stability
    • Mailand N., Podtelejnikov A.V., Groth A., et al. Regulation of G(2)/M events by Cdc25A through phosphorylation-dependent modulation of its stability. EMBO J 2002, 21:5911-5920.
    • (2002) EMBO J , vol.21 , pp. 5911-5920
    • Mailand, N.1    Podtelejnikov, A.V.2    Groth, A.3
  • 25
    • 0030611095 scopus 로고    scopus 로고
    • Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216
    • Peng C.Y., Graves P.R., Thoma R.S., et al. Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science 1997, 277:1501-1505.
    • (1997) Science , vol.277 , pp. 1501-1505
    • Peng, C.Y.1    Graves, P.R.2    Thoma, R.S.3
  • 26
    • 0032974109 scopus 로고    scopus 로고
    • Cytoplasmic localization of human cdc25C during interphase requires an intact 14-3-3 binding site
    • Dalal S.N., Schweitzer C.M., Gan J., DeCaprio J.A. Cytoplasmic localization of human cdc25C during interphase requires an intact 14-3-3 binding site. Mol Cell Biol 1999, 19:4465-4479.
    • (1999) Mol Cell Biol , vol.19 , pp. 4465-4479
    • Dalal, S.N.1    Schweitzer, C.M.2    Gan, J.3    DeCaprio, J.A.4
  • 27
    • 0033561439 scopus 로고    scopus 로고
    • Maintenance of G2 arrest in the Xenopus oocyte: a role for 14-3-3-mediated inhibition of Cdc25 nuclear import
    • Yang J., Winkler K., Yoshida M., Kornbluth S. Maintenance of G2 arrest in the Xenopus oocyte: a role for 14-3-3-mediated inhibition of Cdc25 nuclear import. EMBO J 1999, 18:2174-2183.
    • (1999) EMBO J , vol.18 , pp. 2174-2183
    • Yang, J.1    Winkler, K.2    Yoshida, M.3    Kornbluth, S.4
  • 28
    • 0037415735 scopus 로고    scopus 로고
    • Chk1-deficient tumour cells are viable but exhibit multiple checkpoint and survival defects
    • Zachos G., Rainey M.D., Gillespie D.A. Chk1-deficient tumour cells are viable but exhibit multiple checkpoint and survival defects. EMBO J 2003, 22:713-723.
    • (2003) EMBO J , vol.22 , pp. 713-723
    • Zachos, G.1    Rainey, M.D.2    Gillespie, D.A.3
  • 29
    • 0038013782 scopus 로고    scopus 로고
    • Ataxia-telangiectasia-mutated (ATM) and NBS1-dependent phosphorylation of Chk1 on Ser-317 in response to ionizing radiation
    • Gatei M., Sloper K., Soerensen C., et al. Ataxia-telangiectasia-mutated (ATM) and NBS1-dependent phosphorylation of Chk1 on Ser-317 in response to ionizing radiation. J Biol Chem 2003, 278:14806-14811.
    • (2003) J Biol Chem , vol.278 , pp. 14806-14811
    • Gatei, M.1    Sloper, K.2    Soerensen, C.3
  • 30
    • 0037484271 scopus 로고    scopus 로고
    • Chk1 mediates S and G2 arrests through Cdc25A degradation in response to DNA-damaging agents
    • Xiao Z., Chen Z., Gunasekera A.H., et al. Chk1 mediates S and G2 arrests through Cdc25A degradation in response to DNA-damaging agents. J Biol Chem 2003, 278:21767-21773.
    • (2003) J Biol Chem , vol.278 , pp. 21767-21773
    • Xiao, Z.1    Chen, Z.2    Gunasekera, A.H.3
  • 31
    • 0038418869 scopus 로고    scopus 로고
    • Chk1 and Chk2 kinases in checkpoint control and cancer
    • Bartek J., Lukas J. Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 2003, 3:421-429.
    • (2003) Cancer Cell , vol.3 , pp. 421-429
    • Bartek, J.1    Lukas, J.2
  • 32
    • 3242884449 scopus 로고    scopus 로고
    • The Chk2 protein kinase
    • Ahn J., Urist M., Prives C. The Chk2 protein kinase. DNA Repair 2004, 3:1039-1047.
    • (2004) DNA Repair , vol.3 , pp. 1039-1047
    • Ahn, J.1    Urist, M.2    Prives, C.3
  • 33
    • 0035848819 scopus 로고    scopus 로고
    • The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis
    • Falck J., Mailand N., Syljuasen R.G., et al. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 2001, 410:842-847.
    • (2001) Nature , vol.410 , pp. 842-847
    • Falck, J.1    Mailand, N.2    Syljuasen, R.G.3
  • 34
    • 18644375649 scopus 로고    scopus 로고
    • Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription
    • Takai H., Naka K., Okada Y., et al. Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription. EMBO J 2002, 21:5195-5205.
    • (2002) EMBO J , vol.21 , pp. 5195-5205
    • Takai, H.1    Naka, K.2    Okada, Y.3
  • 35
    • 34247183037 scopus 로고    scopus 로고
    • Cross-talk between Chk1 and Chk2 in double-mutant thymocytes
    • Zaugg K., Su Y.-W., Reilly P.T., et al. Cross-talk between Chk1 and Chk2 in double-mutant thymocytes. Proc Natl Acad Sci, USA 2007, 104:3805-3810.
    • (2007) Proc Natl Acad Sci, USA , vol.104 , pp. 3805-3810
    • Zaugg, K.1    Su, Y.-W.2    Reilly, P.T.3
  • 36
    • 34147206546 scopus 로고    scopus 로고
    • Specific role of Chk1 phosphorylations in cell survival and checkpoint activation
    • Niida H., Katsuno Y., Banerjee B., Hande M.P., Nakanishi M. Specific role of Chk1 phosphorylations in cell survival and checkpoint activation. Mol Cell Biol 2007, 27:2572-2581.
    • (2007) Mol Cell Biol , vol.27 , pp. 2572-2581
    • Niida, H.1    Katsuno, Y.2    Banerjee, B.3    Hande, M.P.4    Nakanishi, M.5
  • 37
    • 33748938889 scopus 로고    scopus 로고
    • The relationship of premature mitosis to cytotoxicity in response to checkpoint abrogation and antimetabolite treatment
    • Morgan M.A., Parsels L.A., Parsels J.D., Lawrence T.S., Maybaum J. The relationship of premature mitosis to cytotoxicity in response to checkpoint abrogation and antimetabolite treatment. Cell Cycle 2006, 5:1983-1988.
    • (2006) Cell Cycle , vol.5 , pp. 1983-1988
    • Morgan, M.A.1    Parsels, L.A.2    Parsels, J.D.3    Lawrence, T.S.4    Maybaum, J.5
  • 38
    • 33748364583 scopus 로고    scopus 로고
    • Differential roles of checkpoint kinase 1, checkpoint kinase 2, and mitogen-activated protein kinase-activated protein kinase 2 in mediating DNA damage-induced cell cycle arrest: implications for cancer therapy
    • Xiao Z., Xue S., Sowin T.J., Zhang H. Differential roles of checkpoint kinase 1, checkpoint kinase 2, and mitogen-activated protein kinase-activated protein kinase 2 in mediating DNA damage-induced cell cycle arrest: implications for cancer therapy. Mol Cancer Ther 2006, 5:1935-1943.
    • (2006) Mol Cancer Ther , vol.5 , pp. 1935-1943
    • Xiao, Z.1    Xue, S.2    Sowin, T.J.3    Zhang, H.4
  • 39
    • 37549009033 scopus 로고    scopus 로고
    • Different S/M checkpoint responses of tumor and non tumor cell lines to DNA replication inhibition
    • Rodriguez-Bravo V., Guaita-Esteruelas S., Salvador N., Bachs O., Agell N. Different S/M checkpoint responses of tumor and non tumor cell lines to DNA replication inhibition. Cancer Research 2007, 67:11648-11656.
    • (2007) Cancer Research , vol.67 , pp. 11648-11656
    • Rodriguez-Bravo, V.1    Guaita-Esteruelas, S.2    Salvador, N.3    Bachs, O.4    Agell, N.5
  • 40
    • 0034655281 scopus 로고    scopus 로고
    • The radiosensitizing agent 7-hydroxystaurosporine (UCN-01) inhibits the DNA damage checkpoint kinase hChk1
    • Busby E.C., Leistritz D.F., Abraham R.T., Karnitz L.M., Sarkaria J.N. The radiosensitizing agent 7-hydroxystaurosporine (UCN-01) inhibits the DNA damage checkpoint kinase hChk1. Cancer Res 2000, 60:2108-2112.
    • (2000) Cancer Res , vol.60 , pp. 2108-2112
    • Busby, E.C.1    Leistritz, D.F.2    Abraham, R.T.3    Karnitz, L.M.4    Sarkaria, J.N.5
  • 43
    • 0033199892 scopus 로고    scopus 로고
    • Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine
    • Sarkaria J.N., Busby E.C., Tibbetts R.S., Roos P., et al. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res 1999, 59:4375-4382.
    • (1999) Cancer Res , vol.59 , pp. 4375-4382
    • Sarkaria, J.N.1    Busby, E.C.2    Tibbetts, R.S.3    Roos, P.4
  • 44
    • 0033555260 scopus 로고    scopus 로고
    • A role for ATR in the DNA damage-induced phosphorylation of p53
    • Tibbetts R.S., Brumbaugh K.M., Williams J.M., et al. A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev 1999, 13:152-157.
    • (1999) Genes Dev , vol.13 , pp. 152-157
    • Tibbetts, R.S.1    Brumbaugh, K.M.2    Williams, J.M.3
  • 45
    • 0035829685 scopus 로고    scopus 로고
    • Inhibition of Chk1-dependent G2 DNA damage checkpoint radiosensitizes p53 mutant human cells
    • Koniaras K., Cuddihy A.R., Christopoulos H., Hogg A., O'Connell M.J. Inhibition of Chk1-dependent G2 DNA damage checkpoint radiosensitizes p53 mutant human cells. Oncogene 2001, 20:7453-7463.
    • (2001) Oncogene , vol.20 , pp. 7453-7463
    • Koniaras, K.1    Cuddihy, A.R.2    Christopoulos, H.3    Hogg, A.4    O'Connell, M.J.5
  • 46
    • 0035062416 scopus 로고    scopus 로고
    • 2 checkpoint specifically sensitize p53 defective cells to cancer chemotherapeutic agents
    • 2 checkpoint specifically sensitize p53 defective cells to cancer chemotherapeutic agents. Anticancer Res 2001, 21:23-28.
    • (2001) Anticancer Res , vol.21 , pp. 23-28
    • Luo, Y.1    Rockow-Magnone, S.K.2    Joseph, M.K.3
  • 47
    • 0034780430 scopus 로고    scopus 로고
    • Blocking Chk1 expression induces apoptosis and abrogates the G2 checkpoint mechanism
    • Luo Y., Rockow-Magnone S.K., Kroeger P.E., et al. Blocking Chk1 expression induces apoptosis and abrogates the G2 checkpoint mechanism. Neoplasia 2001, 3:411-419.
    • (2001) Neoplasia , vol.3 , pp. 411-419
    • Luo, Y.1    Rockow-Magnone, S.K.2    Kroeger, P.E.3
  • 49
    • 36949012288 scopus 로고    scopus 로고
    • Targeted Cancer therapies based on the inhibition of DNA strand break repair
    • O'Connor M.J., Martin N.M.B., Smith G.C.M. Targeted Cancer therapies based on the inhibition of DNA strand break repair. Oncogene 2007, 26:7816-7824.
    • (2007) Oncogene , vol.26 , pp. 7816-7824
    • O'Connor, M.J.1    Martin, N.M.B.2    Smith, G.C.M.3
  • 50
    • 0037241328 scopus 로고    scopus 로고
    • Potentiation of DNA-damage-induced cytotoxicity by G2 checkpoint abrogators
    • Tenzer A., Pruschy M. Potentiation of DNA-damage-induced cytotoxicity by G2 checkpoint abrogators. Curr Med Chem Anticancer Agents 2003, 3:35-46.
    • (2003) Curr Med Chem Anticancer Agents , vol.3 , pp. 35-46
    • Tenzer, A.1    Pruschy, M.2
  • 51
    • 4444344407 scopus 로고    scopus 로고
    • G2 checkpoint abrogators as anticancer drugs
    • Kawabe T. G2 checkpoint abrogators as anticancer drugs. Mol Cancer Ther 2004, 3:513-519.
    • (2004) Mol Cancer Ther , vol.3 , pp. 513-519
    • Kawabe, T.1
  • 53
    • 4444228258 scopus 로고    scopus 로고
    • Combining DNA damaging agents and checkpoint 1 inhibitors
    • Prudhomme M. Combining DNA damaging agents and checkpoint 1 inhibitors. Curr Med Chem Anticancer Agents 2004, 4:435-438.
    • (2004) Curr Med Chem Anticancer Agents , vol.4 , pp. 435-438
    • Prudhomme, M.1
  • 55
    • 33745856631 scopus 로고    scopus 로고
    • Chk1 inhibitors for novel cancer treatment
    • Tao Z.-F., Lin N.-H. Chk1 inhibitors for novel cancer treatment. Anticancer Agents Med Chem 2006, 6:377-388.
    • (2006) Anticancer Agents Med Chem , vol.6 , pp. 377-388
    • Tao, Z.-F.1    Lin, N.-H.2
  • 57
    • 47149114403 scopus 로고    scopus 로고
    • Novel inhibitors of checkpoint kinase 1
    • Arrington K.L., Dudkin V.Y. Novel inhibitors of checkpoint kinase 1. Chemmedchem 2007, 2:1571-1585.
    • (2007) Chemmedchem , vol.2 , pp. 1571-1585
    • Arrington, K.L.1    Dudkin, V.Y.2
  • 58
    • 34247481285 scopus 로고    scopus 로고
    • Targeting checkpoint kinase 1 in cancer therapeutics
    • Tse A.N., Carvajal R., Schwartz G.K. Targeting checkpoint kinase 1 in cancer therapeutics. Clin Cancer Res 2007, 13:1955-1960.
    • (2007) Clin Cancer Res , vol.13 , pp. 1955-1960
    • Tse, A.N.1    Carvajal, R.2    Schwartz, G.K.3
  • 59
    • 79651470785 scopus 로고    scopus 로고
    • Death by releasing the breaks: Chk1 inhibitors as cancer therapeutics
    • Ma C.X., Janetka J.W., Piwnica-Worms H. Death by releasing the breaks: Chk1 inhibitors as cancer therapeutics. Trends Mol Med 2011, 17:88-96.
    • (2011) Trends Mol Med , vol.17 , pp. 88-96
    • Ma, C.X.1    Janetka, J.W.2    Piwnica-Worms, H.3
  • 60
    • 0026616796 scopus 로고
    • Inactivation of the p34cdc2-cyclin B complex by the human WEE1 tyrosine kinase
    • Parker L.L., Piwnica-Worms H. Inactivation of the p34cdc2-cyclin B complex by the human WEE1 tyrosine kinase. Science 1992, 257:1955-1957.
    • (1992) Science , vol.257 , pp. 1955-1957
    • Parker, L.L.1    Piwnica-Worms, H.2
  • 61
    • 0033163714 scopus 로고    scopus 로고
    • Four-dimensional control of the cell cycle
    • Pines J. Four-dimensional control of the cell cycle. Nat Cell Biol 1999, 1:E73-E79.
    • (1999) Nat Cell Biol , vol.1
    • Pines, J.1
  • 62
    • 0027244234 scopus 로고
    • Human wee1 maintains mitotic timing by protecting the nucleus from cytoplasmically activated Cdc2 kinase
    • Heald R., McLoughlin M., McKeon F. Human wee1 maintains mitotic timing by protecting the nucleus from cytoplasmically activated Cdc2 kinase. Cell 1993, 74:463-474.
    • (1993) Cell , vol.74 , pp. 463-474
    • Heald, R.1    McLoughlin, M.2    McKeon, F.3
  • 63
    • 0026006392 scopus 로고
    • Mutations of p34cdc2 phosphorylation sites induce premature mitotic events in HeLa cells: Evidence for a double block to p34cdc2 kinase activation in vertebrates
    • Krek W., Nigg E.A. Mutations of p34cdc2 phosphorylation sites induce premature mitotic events in HeLa cells: Evidence for a double block to p34cdc2 kinase activation in vertebrates. EMBO J 1991, 10:3331-3341.
    • (1991) EMBO J , vol.10 , pp. 3331-3341
    • Krek, W.1    Nigg, E.A.2
  • 64
    • 0025988705 scopus 로고
    • Regulatory phosphorylation of the p34cdc2 protein kinase in vertebrates
    • Norbury C., Blow J., Nurse P. Regulatory phosphorylation of the p34cdc2 protein kinase in vertebrates. EMBO J 1991, 10:3321-3329.
    • (1991) EMBO J , vol.10 , pp. 3321-3329
    • Norbury, C.1    Blow, J.2    Nurse, P.3
  • 65
    • 0029825066 scopus 로고    scopus 로고
    • Role of inhibitory CDC2 phosphorylation in radiation-induced G2 arrest in human cells
    • Jin P., Gu Y., Morgan D.O. Role of inhibitory CDC2 phosphorylation in radiation-induced G2 arrest in human cells. J Cell Biol 1996, 134:963-970.
    • (1996) J Cell Biol , vol.134 , pp. 963-970
    • Jin, P.1    Gu, Y.2    Morgan, D.O.3
  • 66
    • 0032484084 scopus 로고    scopus 로고
    • Linkage of ATM to cell cycle regulation by the Chk2 protein kinase
    • Matsuoka S., Huang M., Elledge S.J. Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science 1998, 282:1893-1897.
    • (1998) Science , vol.282 , pp. 1893-1897
    • Matsuoka, S.1    Huang, M.2    Elledge, S.J.3
  • 67
    • 0030867582 scopus 로고    scopus 로고
    • Conservation of the Chk1 checkpoint pathway in mammals: Linkage of DNA damage to Cdk regulation through Cdc25
    • Sanchez Y., Wong C., Thoma R.S., et al. Conservation of the Chk1 checkpoint pathway in mammals: Linkage of DNA damage to Cdk regulation through Cdc25. Science 1997, 277:1497-1501.
    • (1997) Science , vol.277 , pp. 1497-1501
    • Sanchez, Y.1    Wong, C.2    Thoma, R.S.3
  • 68
    • 0031035528 scopus 로고    scopus 로고
    • Chk1 is a wee1 kinase in the G2 DNA damage checkpoint inhibiting cdc2 by Y15 phosphorylation
    • O'Connell M.J., Raleigh J.M., Verkade H.M., Nurse P. Chk1 is a wee1 kinase in the G2 DNA damage checkpoint inhibiting cdc2 by Y15 phosphorylation. EMBO J 1997, 16:545-554.
    • (1997) EMBO J , vol.16 , pp. 545-554
    • O'Connell, M.J.1    Raleigh, J.M.2    Verkade, H.M.3    Nurse, P.4
  • 69
    • 0034125688 scopus 로고    scopus 로고
    • The G2 DNA damage checkpoint targets both Wee1 and Cdc25
    • Raleigh J.M., O'Connell M.J. The G2 DNA damage checkpoint targets both Wee1 and Cdc25. J Cell Sci 2000, 113:1727-1736.
    • (2000) J Cell Sci , vol.113 , pp. 1727-1736
    • Raleigh, J.M.1    O'Connell, M.J.2
  • 70
    • 0035158899 scopus 로고    scopus 로고
    • Positive regulation of Wee1 by Chk1 and 14-3-3 proteins
    • Lee J., Kumagai A., Dunphy W.G. Positive regulation of Wee1 by Chk1 and 14-3-3 proteins. Mol Biol Cell 2000, 12:551-563.
    • (2000) Mol Biol Cell , vol.12 , pp. 551-563
    • Lee, J.1    Kumagai, A.2    Dunphy, W.G.3
  • 71
    • 0035890610 scopus 로고    scopus 로고
    • Radiosensitization of p53 mutant cells by PD0166285, a novel G(2) checkpoint abrogator
    • Wang Y., Li J., Booher R.N., et al. Radiosensitization of p53 mutant cells by PD0166285, a novel G(2) checkpoint abrogator. Cancer Res 2001, 61:8211-8217.
    • (2001) Cancer Res , vol.61 , pp. 8211-8217
    • Wang, Y.1    Li, J.2    Booher, R.N.3
  • 72
    • 16544392882 scopus 로고    scopus 로고
    • Knockdown of Chk1, Wee1 and Myt1 by RNA interference abrogates G2 checkpoint and induces apoptosis
    • Wang Y., Decker S.J., Sebolt-Leopold J. Knockdown of Chk1, Wee1 and Myt1 by RNA interference abrogates G2 checkpoint and induces apoptosis. Cancer Biol Ther 2004, 3:305-313.
    • (2004) Cancer Biol Ther , vol.3 , pp. 305-313
    • Wang, Y.1    Decker, S.J.2    Sebolt-Leopold, J.3
  • 73
    • 70949083026 scopus 로고    scopus 로고
    • Small molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53-deficient tumor cells to DNA-damaging agents
    • Hirai H., Iwasawa Y., Okada M., et al. Small molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53-deficient tumor cells to DNA-damaging agents. Mol Cancer Ther 2009, 8:2992-3000.
    • (2009) Mol Cancer Ther , vol.8 , pp. 2992-3000
    • Hirai, H.1    Iwasawa, Y.2    Okada, M.3
  • 74
    • 3142615903 scopus 로고
    • Mechanism by which caffeine potentiates lethality of nitrogen mustard
    • Lau C.C., Pardee A.B. Mechanism by which caffeine potentiates lethality of nitrogen mustard. Proc Natl Acad Sci USA 1982, 79:2942-2946.
    • (1982) Proc Natl Acad Sci USA , vol.79 , pp. 2942-2946
    • Lau, C.C.1    Pardee, A.B.2
  • 75
    • 0020367120 scopus 로고
    • Abolition by cycloheximide of caffeine-enhanced lethality of alkylating agents in hamster cells
    • Das S.K., Lau C.C., Pardee A.B. Abolition by cycloheximide of caffeine-enhanced lethality of alkylating agents in hamster cells. Cancer Res 1982, 42:4499-4504.
    • (1982) Cancer Res , vol.42 , pp. 4499-4504
    • Das, S.K.1    Lau, C.C.2    Pardee, A.B.3
  • 76
    • 0025282246 scopus 로고
    • Override of the radiation-induced mitotic block in human tumor cells by methylxanthines and its relationship to the potentiation of cytotoxicity
    • Musk S.R., Steel G.G. Override of the radiation-induced mitotic block in human tumor cells by methylxanthines and its relationship to the potentiation of cytotoxicity. Int J Radiat Biol 1990, 57:1105-1112.
    • (1990) Int J Radiat Biol , vol.57 , pp. 1105-1112
    • Musk, S.R.1    Steel, G.G.2
  • 77
    • 0025838748 scopus 로고
    • Efficacy of pentoxyfylline as a modulator of alkylating agent activity in vitro and in vivo
    • Teicher B.A., Holden S.A., Herman T.S., Epelbaum R., Pardee A.B., Dezube B. Efficacy of pentoxyfylline as a modulator of alkylating agent activity in vitro and in vivo. Anticancer Res 1991, 11:1555-1560.
    • (1991) Anticancer Res , vol.11 , pp. 1555-1560
    • Teicher, B.A.1    Holden, S.A.2    Herman, T.S.3    Epelbaum, R.4    Pardee, A.B.5    Dezube, B.6
  • 78
    • 0032903795 scopus 로고    scopus 로고
    • Caffeine-increased radiosensitivity is not dependent on a loss of G2/M arrest or apoptosis in bladder cancer cell lines
    • Ribeiro J.C., Barnetson A.R., Jackson P., Ow K., Links M., Russell P.J. Caffeine-increased radiosensitivity is not dependent on a loss of G2/M arrest or apoptosis in bladder cancer cell lines. Int J Radiat Biol 1999, 75:481-492.
    • (1999) Int J Radiat Biol , vol.75 , pp. 481-492
    • Ribeiro, J.C.1    Barnetson, A.R.2    Jackson, P.3    Ow, K.4    Links, M.5    Russell, P.J.6
  • 79
  • 80
    • 0035393498 scopus 로고    scopus 로고
    • Pharmacological inhibitors of the mitogen-activated protein kinase (MAPK) kinase/MAPK cascade interact synergistically with UCN-01 to induce mitochondrial dysfunction and apoptosis in human leukemia cells
    • Dai Y., Yu C., Singh V., et al. Pharmacological inhibitors of the mitogen-activated protein kinase (MAPK) kinase/MAPK cascade interact synergistically with UCN-01 to induce mitochondrial dysfunction and apoptosis in human leukemia cells. Cancer Res 2001, 61:5106-5115.
    • (2001) Cancer Res , vol.61 , pp. 5106-5115
    • Dai, Y.1    Yu, C.2    Singh, V.3
  • 81
    • 0029871688 scopus 로고    scopus 로고
    • UCN-01, 7-hydroxyl-staurosporine, inhibits kinase activity of cyclin-dependent kinases and reduces the phosphorylation of the retinoblastoma susceptibility gene product in A549 human lung cancer cell line
    • Kawakami K., Futami H., Takahara J., Yamaguchi K. UCN-01, 7-hydroxyl-staurosporine, inhibits kinase activity of cyclin-dependent kinases and reduces the phosphorylation of the retinoblastoma susceptibility gene product in A549 human lung cancer cell line. Biochem Biophys Res Commun 1996, 219:778-783.
    • (1996) Biochem Biophys Res Commun , vol.219 , pp. 778-783
    • Kawakami, K.1    Futami, H.2    Takahara, J.3    Yamaguchi, K.4
  • 82
    • 0034040974 scopus 로고    scopus 로고
    • UCN-01 (7-hydroxystaurosporine) and other indolocarbazole compounds: a new generation of anti-cancer agents for the new century
    • Akinaga S., Sugiyama K., Akiyama T. UCN-01 (7-hydroxystaurosporine) and other indolocarbazole compounds: a new generation of anti-cancer agents for the new century. Anticancer Drug Des 2000, 15:43-52.
    • (2000) Anticancer Drug Des , vol.15 , pp. 43-52
    • Akinaga, S.1    Sugiyama, K.2    Akiyama, T.3
  • 83
    • 0026425587 scopus 로고
    • Antitumor activity of UCN-01, a selective inhibitor of protein kinase C, in murine and human tumor models
    • Akinaga S., Gomi K., Morimoto M., Tamaoki T., Okabe M. Antitumor activity of UCN-01, a selective inhibitor of protein kinase C, in murine and human tumor models. Cancer Res 1991, 51:4888-4892.
    • (1991) Cancer Res , vol.51 , pp. 4888-4892
    • Akinaga, S.1    Gomi, K.2    Morimoto, M.3    Tamaoki, T.4    Okabe, M.5
  • 84
    • 19944432818 scopus 로고    scopus 로고
    • The broad-range cyclin-dependent kinase inhibitor UCN-01 induces apoptosis in colon carcinoma cells through transcriptional suppression of the Bcl-xL protein
    • Bhonde M.R., Hanski M.-L., Magrini R. The broad-range cyclin-dependent kinase inhibitor UCN-01 induces apoptosis in colon carcinoma cells through transcriptional suppression of the Bcl-xL protein. Oncogene 2005, 24:148-156.
    • (2005) Oncogene , vol.24 , pp. 148-156
    • Bhonde, M.R.1    Hanski, M.-L.2    Magrini, R.3
  • 85
    • 0033913696 scopus 로고    scopus 로고
    • Inhibition of CDKs as a therapeutic modality
    • Sausville E.A., Johnson J., Alley M., et al. Inhibition of CDKs as a therapeutic modality. Ann NY Acad Sci 2000, 910:207-221.
    • (2000) Ann NY Acad Sci , vol.910 , pp. 207-221
    • Sausville, E.A.1    Johnson, J.2    Alley, M.3
  • 86
    • 0029992520 scopus 로고    scopus 로고
    • Enhancement of cisplatin-induced cytotoxicity by 7-hydroxystaurosporine (UCN-01), a new G2 checkpoint inhibitor
    • Bunch R.T., Eastman A. Enhancement of cisplatin-induced cytotoxicity by 7-hydroxystaurosporine (UCN-01), a new G2 checkpoint inhibitor. Clin Cancer Res 1996, 2:791-797.
    • (1996) Clin Cancer Res , vol.2 , pp. 791-797
    • Bunch, R.T.1    Eastman, A.2
  • 87
    • 0033953099 scopus 로고    scopus 로고
    • UCN-01 Selectively enhances mitomycin C cytotoxicity in p53 defective cells which is mediated through S and/or G(2) checkpoint abrogation
    • Sugiyama K., Shimizu M., Akiyama T., et al. UCN-01 Selectively enhances mitomycin C cytotoxicity in p53 defective cells which is mediated through S and/or G(2) checkpoint abrogation. Int J Cancer 2000, 85:703-709.
    • (2000) Int J Cancer , vol.85 , pp. 703-709
    • Sugiyama, K.1    Shimizu, M.2    Akiyama, T.3
  • 88
    • 31544452150 scopus 로고    scopus 로고
    • Phase I trial of UCN-01 in combination with topotecan in patients with advanced solid cancers: A Princess Margaret hospital phase II consortium study
    • Hotte S.J., Oza A., Winquist E.W., et al. Phase I trial of UCN-01 in combination with topotecan in patients with advanced solid cancers: A Princess Margaret hospital phase II consortium study. Ann Oncol 2006, 17:334-340.
    • (2006) Ann Oncol , vol.17 , pp. 334-340
    • Hotte, S.J.1    Oza, A.2    Winquist, E.W.3
  • 89
    • 33746388284 scopus 로고    scopus 로고
    • Modulation of cell cycle progression in human tumors: A pharmacokinetic and tumor molecular pharmacodynamic study of cisplatin plus the Chk1 inhibitor UCN-01 (NSC 638850)
    • Perez R.P., Lewis L.D., Beelen A.P., et al. Modulation of cell cycle progression in human tumors: A pharmacokinetic and tumor molecular pharmacodynamic study of cisplatin plus the Chk1 inhibitor UCN-01 (NSC 638850). Clin Cancer Res 2006, 12:7079-7085.
    • (2006) Clin Cancer Res , vol.12 , pp. 7079-7085
    • Perez, R.P.1    Lewis, L.D.2    Beelen, A.P.3
  • 90
    • 33644755493 scopus 로고    scopus 로고
    • Pharmacodynamics of cytarabine alone and in combination with 7-hydroxystaurosporine (UCN-01) in AML blasts in vitro and during a clinical trial
    • Sampath D., Cortes J., Estrov Z., et al. Pharmacodynamics of cytarabine alone and in combination with 7-hydroxystaurosporine (UCN-01) in AML blasts in vitro and during a clinical trial. Blood 2006, 107:2517-2524.
    • (2006) Blood , vol.107 , pp. 2517-2524
    • Sampath, D.1    Cortes, J.2    Estrov, Z.3
  • 91
    • 0346452207 scopus 로고    scopus 로고
    • The cyclin-dependent kinase (CDK) Inhibitor UCN-01 plus cisplatin in advanced solid tumors: A California Cancer Consortium Phase I Trial
    • Abst 987
    • Gandara D.R., Lara P.N., Longmate J., et al. The cyclin-dependent kinase (CDK) Inhibitor UCN-01 plus cisplatin in advanced solid tumors: A California Cancer Consortium Phase I Trial. Proc Am Soc Clin Oncol (ASCO) 2003, 22. Abst 987.
    • (2003) Proc Am Soc Clin Oncol (ASCO) , vol.22
    • Gandara, D.R.1    Lara, P.N.2    Longmate, J.3
  • 92
    • 71349083859 scopus 로고    scopus 로고
    • A phase I trial of UCN-01 and prednisone in patients with refractory solid tumors and lymphomas
    • Kummar S., Guiterrez M.E., Gardener E.R., et al. A phase I trial of UCN-01 and prednisone in patients with refractory solid tumors and lymphomas. Cancer Chemother Pharmacol 2010, 65:383-389.
    • (2010) Cancer Chemother Pharmacol , vol.65 , pp. 383-389
    • Kummar, S.1    Guiterrez, M.E.2    Gardener, E.R.3
  • 93
    • 33846567414 scopus 로고    scopus 로고
    • Pharmacological abrogation of S-phase checkpoint enhances the anti-tumor activity of gemcitabine in vivo
    • Mathews D.J., Yakes F.M., Chen J., et al. Pharmacological abrogation of S-phase checkpoint enhances the anti-tumor activity of gemcitabine in vivo. Cell Cycle 2007, 6:104-110.
    • (2007) Cell Cycle , vol.6 , pp. 104-110
    • Mathews, D.J.1    Yakes, F.M.2    Chen, J.3
  • 94
    • 34447628254 scopus 로고    scopus 로고
    • Inhibition of CHKs in a leukemia model abrogates DNA damage checkpoints and promotes mitotic catastrophe
    • Abst 5385
    • Clary D.O. Inhibition of CHKs in a leukemia model abrogates DNA damage checkpoints and promotes mitotic catastrophe. Proc Am Assoc Cancer Res 2007, 48. Abst 5385.
    • (2007) Proc Am Assoc Cancer Res , vol.48
    • Clary, D.O.1
  • 95
    • 2342635919 scopus 로고    scopus 로고
    • Cell death by mitotic catastrophe: a molecular definition
    • Castedo M., Perfettinin J.-L., Roumier T., et al. Cell death by mitotic catastrophe: a molecular definition. Oncogene 2004, 23:2825-2837.
    • (2004) Oncogene , vol.23 , pp. 2825-2837
    • Castedo, M.1    Perfettinin, J.-L.2    Roumier, T.3
  • 96
    • 38949195786 scopus 로고    scopus 로고
    • Dissecting the roles of Chk1 and Chk2 in mitotic catastrophe using chemical genetics
    • Abst 344
    • Matthews D.J. Dissecting the roles of Chk1 and Chk2 in mitotic catastrophe using chemical genetics. Eur J Cancer 2006, 4. Abst 344.
    • (2006) Eur J Cancer , vol.4
    • Matthews, D.J.1
  • 97
    • 84882409088 scopus 로고    scopus 로고
    • Phase 1 study of XL844, a novel Chk1 and Chk2 kinase inhibitor, in combination with gemcitabine in subjects with advanced malignancies
    • Abst 395
    • Tse A.N., Yazji S., Naing A., et al. Phase 1 study of XL844, a novel Chk1 and Chk2 kinase inhibitor, in combination with gemcitabine in subjects with advanced malignancies. Eur J Cancer Suppl 2008, 6. Abst 395.
    • (2008) Eur J Cancer Suppl , vol.6
    • Tse, A.N.1    Yazji, S.2    Naing, A.3
  • 98
    • 1842450527 scopus 로고    scopus 로고
    • Identification of compounds with nanomolar binding affinity for checkpoint kinase-1 using knowledge-based virtual screening
    • Lyne P.D., Kenny P.W., Cosgrove D.A., et al. Identification of compounds with nanomolar binding affinity for checkpoint kinase-1 using knowledge-based virtual screening. J Med Chem 2004, 47:1962-1968.
    • (2004) J Med Chem , vol.47 , pp. 1962-1968
    • Lyne, P.D.1    Kenny, P.W.2    Cosgrove, D.A.3
  • 99
    • 84882311402 scopus 로고    scopus 로고
    • Preclinical identification of AZD7762, a novel, potent and selective inhibitor of Checkpoint kinases
    • Abst A232
    • Ashwell S., Caleb B., Deng C., et al. Preclinical identification of AZD7762, a novel, potent and selective inhibitor of Checkpoint kinases. Mol Cancer Ther 2007, 6. Abst A232.
    • (2007) Mol Cancer Ther , vol.6
    • Ashwell, S.1    Caleb, B.2    Deng, C.3
  • 100
    • 84882342148 scopus 로고    scopus 로고
    • Structure activity and structure property relationships of a novel series of potent inhibitors of Checkpoint kinases
    • Abst A233
    • Almeida L., Ashwell S., Ayres D., et al. Structure activity and structure property relationships of a novel series of potent inhibitors of Checkpoint kinases. Mol Cancer Ther 2007, 6. Abst A233.
    • (2007) Mol Cancer Ther , vol.6
    • Almeida, L.1    Ashwell, S.2    Ayres, D.3
  • 101
    • 52949139387 scopus 로고    scopus 로고
    • AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies
    • Zabludoff S., Deng C., Grondine M., et al. AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies. Mol Cancer Ther 2008, 7:2955-2966.
    • (2008) Mol Cancer Ther , vol.7 , pp. 2955-2966
    • Zabludoff, S.1    Deng, C.2    Grondine, M.3
  • 102
    • 47149091445 scopus 로고    scopus 로고
    • Discovery of a novel class of 2-ureido thiophene carboxamide checkpoint kinase inhibitors
    • Janetka J., Almeida L., Ashwell S., et al. Discovery of a novel class of 2-ureido thiophene carboxamide checkpoint kinase inhibitors. Bioorg Med Chem Letts 2008, 18:4242-4248.
    • (2008) Bioorg Med Chem Letts , vol.18 , pp. 4242-4248
    • Janetka, J.1    Almeida, L.2    Ashwell, S.3
  • 103
    • 77950650401 scopus 로고    scopus 로고
    • In vitro and in vivo radiosensitization of human tumor cells by a novel checkpoint kinase inhibitor, AZD7762
    • Mitchell J.B., Choudhuri R., Fabre K., et al. In vitro and in vivo radiosensitization of human tumor cells by a novel checkpoint kinase inhibitor, AZD7762. Clin Cancer Res 2010, 16:2076-2084.
    • (2010) Clin Cancer Res , vol.16 , pp. 2076-2084
    • Mitchell, J.B.1    Choudhuri, R.2    Fabre, K.3
  • 104
    • 77953770987 scopus 로고    scopus 로고
    • Mechanism of radiosensitization by the Chk1/2 inhibitor AZD7762 involves abrogation of the G2 checkpoint and inhibition of homologous recombinational DNA repair
    • Morgan M.A., Parsels L.A., Zhao L., et al. Mechanism of radiosensitization by the Chk1/2 inhibitor AZD7762 involves abrogation of the G2 checkpoint and inhibition of homologous recombinational DNA repair. Cancer Res 2010, 70:4972-4991.
    • (2010) Cancer Res , vol.70 , pp. 4972-4991
    • Morgan, M.A.1    Parsels, L.A.2    Zhao, L.3
  • 105
    • 1642471800 scopus 로고    scopus 로고
    • Mechanisms of apoptosis induction by nucleoside analogs
    • Sampath D., Rao V.A., Plunkett W. Mechanisms of apoptosis induction by nucleoside analogs. Oncogene 2003, 22:9063-9074.
    • (2003) Oncogene , vol.22 , pp. 9063-9074
    • Sampath, D.1    Rao, V.A.2    Plunkett, W.3
  • 106
    • 33645825609 scopus 로고    scopus 로고
    • Chk1 requirement for high global rates of replication fork progression during normal vertebrate S phase
    • Petermann E., Maya-Mendoza A., Zachos G., et al. Chk1 requirement for high global rates of replication fork progression during normal vertebrate S phase. Mol Cell Biol 2006, 26:3319-3326.
    • (2006) Mol Cell Biol , vol.26 , pp. 3319-3326
    • Petermann, E.1    Maya-Mendoza, A.2    Zachos, G.3
  • 107
    • 27844561114 scopus 로고    scopus 로고
    • Gemcitabine-induced activation of checkpoint signaling pathways that affect tumor cell survival
    • Karnitz L.M., Flatten K.S., Wagner J.M., et al. Gemcitabine-induced activation of checkpoint signaling pathways that affect tumor cell survival. Mol Pharmacol 2005, 68:1636-1644.
    • (2005) Mol Pharmacol , vol.68 , pp. 1636-1644
    • Karnitz, L.M.1    Flatten, K.S.2    Wagner, J.M.3
  • 108
    • 17144377827 scopus 로고    scopus 로고
    • The role of checkpoint kinase 1 in sensitivity to topoisomerase I poisons
    • Flatten K., Dai N.T., Vroman B.T., et al. The role of checkpoint kinase 1 in sensitivity to topoisomerase I poisons. J Biol Chem 2005, 280:14349-14355.
    • (2005) J Biol Chem , vol.280 , pp. 14349-14355
    • Flatten, K.1    Dai, N.T.2    Vroman, B.T.3
  • 109
    • 34447625126 scopus 로고    scopus 로고
    • A novel inhibitor of the protein kinase Chk1: Studies on the mechanism of action
    • Abst 4416
    • Blasina A., Kornmann J.F., Chen E., et al. A novel inhibitor of the protein kinase Chk1: Studies on the mechanism of action. Proc Am Assoc Cancer Res 2005, 46. Abst 4416.
    • (2005) Proc Am Assoc Cancer Res , vol.46
    • Blasina, A.1    Kornmann, J.F.2    Chen, E.3
  • 110
    • 33745816633 scopus 로고    scopus 로고
    • Small molecule Chk1 inhibitor potentiates antitumour activity of chemotherapeutic agents in vivo
    • Abst 4417
    • Anderes K.L., Blasina A., Castillo R., et al. Small molecule Chk1 inhibitor potentiates antitumour activity of chemotherapeutic agents in vivo. Proc Am. Assoc Cancer Res 2005, 46. Abst 4417.
    • (2005) Proc Am. Assoc Cancer Res , vol.46
    • Anderes, K.L.1    Blasina, A.2    Castillo, R.3
  • 111
    • 84882427713 scopus 로고    scopus 로고
    • Imaging with FLT-PET demonstrates that PF00477736, an inhibitor of Chk1 kinase, overcomes a cell cycle checkpoint induced by gemcitabine in PC-3 xenografts
    • Abst 3045
    • McArthur G.A. Imaging with FLT-PET demonstrates that PF00477736, an inhibitor of Chk1 kinase, overcomes a cell cycle checkpoint induced by gemcitabine in PC-3 xenografts. Proc Am Soc Clin Oncol 2006, 25. Abst 3045.
    • (2006) Proc Am Soc Clin Oncol , vol.25
    • McArthur, G.A.1
  • 112
    • 84882322669 scopus 로고    scopus 로고
    • Characterization of a novel and selective inhibitor of checkpoint kinase 1: Breaching the tumour's last checkpoint defense against chemotherapeutic agents
    • Blasina A., Kornmann J.F., Chen E., et al. Characterization of a novel and selective inhibitor of checkpoint kinase 1: Breaching the tumour's last checkpoint defense against chemotherapeutic agents. Eur J Cancer Suppl 2006, 4:115.
    • (2006) Eur J Cancer Suppl , vol.4 , pp. 115
    • Blasina, A.1    Kornmann, J.F.2    Chen, E.3
  • 113
    • 34447638042 scopus 로고    scopus 로고
    • PF00477736 an inhibitor of Chk1 enhances the antitumour activity of docetaxel indicating a role for Chk1 in the mitotic spindle checkpoint
    • Abst 4373
    • Hallin M., Zhang C., Yan Z., et al. PF00477736 an inhibitor of Chk1 enhances the antitumour activity of docetaxel indicating a role for Chk1 in the mitotic spindle checkpoint. Proc Am Assoc Cancer Res 2007, 48. Abst 4373.
    • (2007) Proc Am Assoc Cancer Res , vol.48
    • Hallin, M.1    Zhang, C.2    Yan, Z.3
  • 115
    • 33947517675 scopus 로고    scopus 로고
    • Mechanisms of radiation enhancement by the Chk1 inhibitor PF00477736
    • Li G., Elder R.T., Qin K., et al. Mechanisms of radiation enhancement by the Chk1 inhibitor PF00477736. J Biol Chem 2007, 282:7287-7298.
    • (2007) J Biol Chem , vol.282 , pp. 7287-7298
    • Li, G.1    Elder, R.T.2    Qin, K.3
  • 116
    • 79958804691 scopus 로고    scopus 로고
    • Phase I clinical trial of gemcitabine (GEM) in combination with PF00477736 (PF-736), a selective inhibitor of Chk1 kinase
    • Abst 3062
    • Brega N., McArthur G.A., Britten C., et al. Phase I clinical trial of gemcitabine (GEM) in combination with PF00477736 (PF-736), a selective inhibitor of Chk1 kinase. J Clin Oncol 2010, 28. Abst 3062.
    • (2010) J Clin Oncol , vol.28
    • Brega, N.1    McArthur, G.A.2    Britten, C.3
  • 117
    • 84882358250 scopus 로고    scopus 로고
    • Discovery of pyrazinyl ureas as inhibitors of the cell-cycle checkpoint kinase Chk1
    • Presented at 228th ACS National Meeting, Philadelphia, USA, 22-26 August
    • Kesicki EA, Gaudino JJ, Cook AW, et al. Discovery of pyrazinyl ureas as inhibitors of the cell-cycle checkpoint kinase Chk1. Presented at 228th ACS National Meeting, Philadelphia, USA, 22-26 August 2004.
    • (2004)
    • Kesicki, E.A.1    Gaudino, J.J.2    Cook, A.W.3
  • 118
    • 84882351680 scopus 로고    scopus 로고
    • Characterization and preclinical development of LY2606368, a second generation Chk1 inhibitor. Presented at 22nd EORTC-NCI-AACR symposium on "Molecular targets and Cancer Therapeutics," Berlin, Germany, 16-19 November
    • Marshall M, King C, Barnard H, et al. Characterization and preclinical development of LY2606368, a second generation Chk1 inhibitor. Presented at 22nd EORTC-NCI-AACR symposium on "Molecular targets and Cancer Therapeutics," Berlin, Germany, 16-19 November 2010.
    • (2010)
    • Marshall, M.1    King, C.2    Barnard, H.3
  • 119
    • 84882334052 scopus 로고    scopus 로고
    • Evaluation of the antitumor activity of pemetrexed in combination with the Chk1 inhibitor LY2603618. Presented at 22nd EORTC-NCI-AACR symposium on "Molecular Targets and Cancer Therapeutics," Berlin, Germany, 16-19 November
    • Marshall M, Barnard D, Diaz H, et al. Evaluation of the antitumor activity of pemetrexed in combination with the Chk1 inhibitor LY2603618. Presented at 22nd EORTC-NCI-AACR symposium on "Molecular Targets and Cancer Therapeutics," Berlin, Germany, 16-19 November 2010.
    • (2010)
    • Marshall, M.1    Barnard, D.2    Diaz, H.3
  • 120
    • 84882350076 scopus 로고    scopus 로고
    • A phase 1 dose-escalation study to examine the safety and tolerability of LY2603618 administered 1 day after pemetrexed 500 mg/m2 every 21 days in patients with cancer. Presented at 22nd EORTC-NCI-AACR symposium on "Molecular Targets and Cancer Therapeutics," Berlin, Germany, 16-19 November
    • Weiss G, Donehower E, Westin A, et al. A phase 1 dose-escalation study to examine the safety and tolerability of LY2603618 administered 1 day after pemetrexed 500 mg/m2 every 21 days in patients with cancer. Presented at 22nd EORTC-NCI-AACR symposium on "Molecular Targets and Cancer Therapeutics," Berlin, Germany, 16-19 November 2010.
    • (2010)
    • Weiss, G.1    Donehower, E.2    Westin, A.3
  • 121
    • 79651472860 scopus 로고    scopus 로고
    • Targeting the replication checkpoint with a potent and selective Chk1 inhibitor
    • Presented at 2009 AACR Annual Meeting, Denver, USA, 18-22April
    • Parry DA. Targeting the replication checkpoint with a potent and selective Chk1 inhibitor. Presented at 2009 AACR Annual Meeting, Denver, USA, 18-22April 2009.
    • (2009)
    • Parry, D.A.1
  • 122
    • 84882426654 scopus 로고    scopus 로고
    • Efficacy of the Chk1 inhibitor SCH-900776 at abrogating cell cycle arrest and enhancing DNA damage-induced cytotoxicity: comparison with UCN-01. Presented at 2010 AACR Annual Meeting, Washington, DC, USA, 17-21 April
    • Eastman A, Montano RE, Garner KM, et al. Efficacy of the Chk1 inhibitor SCH-900776 at abrogating cell cycle arrest and enhancing DNA damage-induced cytotoxicity: comparison with UCN-01. Presented at 2010 AACR Annual Meeting, Washington, DC, USA, 17-21 April 2010.
    • (2010)
    • Eastman, A.1    Montano, R.E.2    Garner, K.M.3
  • 123
    • 79651475663 scopus 로고    scopus 로고
    • Phase I dose-escalation study of SCH 900776, a selective inhibitor of checkpoint kinase 1 (Chk1), in combination with gemcitabine (Gem) in subjects with advanced solid tumors
    • Abst 3064
    • Daud A.A. phase I dose-escalation study of SCH 900776, a selective inhibitor of checkpoint kinase 1 (Chk1), in combination with gemcitabine (Gem) in subjects with advanced solid tumors. J Clin Oncol 2010, 15s. Abst 3064.
    • (2010) J Clin Oncol , vol.15 s
    • Daud, A.A.1
  • 124
    • 0028783413 scopus 로고
    • Myt1: a membrane-associated inhibitory kinase that phosphorylates Cdc2 on both threonine-14 and tyrosine-15
    • Mueller P.R., Coleman T.R., Kumagai A., Dunphy W.G. Myt1: a membrane-associated inhibitory kinase that phosphorylates Cdc2 on both threonine-14 and tyrosine-15. Science 1995, 270:86-90.
    • (1995) Science , vol.270 , pp. 86-90
    • Mueller, P.R.1    Coleman, T.R.2    Kumagai, A.3    Dunphy, W.G.4
  • 125
    • 84882380343 scopus 로고    scopus 로고
    • Preclinical in vivo evaluation of a novel treatment strategy combining a Wee1 inhibitor with radiotherapy
    • Abst 10596
    • Mason K., Pickett C., Ware H., et al. Preclinical in vivo evaluation of a novel treatment strategy combining a Wee1 inhibitor with radiotherapy. J Clin Oncol 2010, 15s. Abst 10596.
    • (2010) J Clin Oncol , vol.15 s
    • Mason, K.1    Pickett, C.2    Ware, H.3
  • 126
    • 79956224870 scopus 로고    scopus 로고
    • Phase I pharmacological and pharmacodynamic study of MK-1775, a Wee1 tyrosine kinase inhibitor, in monotherapy and combination with gemcitabine, cisplatin, or carboplatin in patients with advanced solid tumors
    • Abst 3067
    • Leijen S., Schellens J.H., Shapiro G., et al. Phase I pharmacological and pharmacodynamic study of MK-1775, a Wee1 tyrosine kinase inhibitor, in monotherapy and combination with gemcitabine, cisplatin, or carboplatin in patients with advanced solid tumors. J Clin Oncol 2010, 15s. Abst 3067.
    • (2010) J Clin Oncol , vol.15 s
    • Leijen, S.1    Schellens, J.H.2    Shapiro, G.3
  • 127
    • 0033566082 scopus 로고    scopus 로고
    • Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway
    • Chaturvedi P., Eng W.K., Zhu Y., et al. Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway. Oncogene 1999, 18:4047-4054.
    • (1999) Oncogene , vol.18 , pp. 4047-4054
    • Chaturvedi, P.1    Eng, W.K.2    Zhu, Y.3
  • 128
    • 9244251125 scopus 로고    scopus 로고
    • Cell cycle checkpoints and cancer
    • Kastan M.B., Bartek J. Cell cycle checkpoints and cancer. Nature 2004, 432:316-323.
    • (2004) Nature , vol.432 , pp. 316-323
    • Kastan, M.B.1    Bartek, J.2
  • 129
    • 38949133032 scopus 로고    scopus 로고
    • Chk2 is required for optimal mitotic delay in response to irradiation-induced DNA damage incurred in G2 phase
    • Rainey M.D., Black E.J., Zachos G., Gillespie D.A. Chk2 is required for optimal mitotic delay in response to irradiation-induced DNA damage incurred in G2 phase. Oncogene 2008, 27:896-906.
    • (2008) Oncogene , vol.27 , pp. 896-906
    • Rainey, M.D.1    Black, E.J.2    Zachos, G.3    Gillespie, D.A.4
  • 130
    • 34147177714 scopus 로고    scopus 로고
    • Biochemical and cellular characterization of VRX0466617, a novel and selective inhibitor for the checkpoint kinase Chk2
    • Carlessi L., Buscemi G., Larson G., et al. Biochemical and cellular characterization of VRX0466617, a novel and selective inhibitor for the checkpoint kinase Chk2. Mol Cancer Ther 2007, 6:935-944.
    • (2007) Mol Cancer Ther , vol.6 , pp. 935-944
    • Carlessi, L.1    Buscemi, G.2    Larson, G.3
  • 131
    • 0036724625 scopus 로고    scopus 로고
    • Chk2 is a tumor suppressor that regulates apoptosis in both an ATM-dependent and ATM independent manner
    • Hirao A., Cheung A., Cuncan G., et al. Chk2 is a tumor suppressor that regulates apoptosis in both an ATM-dependent and ATM independent manner. Mol Cell Biol 2002, 22:6521-6532.
    • (2002) Mol Cell Biol , vol.22 , pp. 6521-6532
    • Hirao, A.1    Cheung, A.2    Cuncan, G.3
  • 132
    • 0037162506 scopus 로고    scopus 로고
    • Chk2 is dispensable for p53-mediated G1 arrest but is required for a latent p53-mediated apoptotic response
    • Jack M.T., Woo R.A., Hirao A., et al. Chk2 is dispensable for p53-mediated G1 arrest but is required for a latent p53-mediated apoptotic response. Proc Natl Acad Sci USA 2002, 99:9825-9829.
    • (2002) Proc Natl Acad Sci USA , vol.99 , pp. 9825-9829
    • Jack, M.T.1    Woo, R.A.2    Hirao, A.3
  • 133
    • 0034629072 scopus 로고    scopus 로고
    • DNA damage-induced activation of p53 by the checkpoint kinase Chk2
    • Hirao A., Kong Y.Y., Matsuoka S., et al. DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 2000, 287:1824-1827.
    • (2000) Science , vol.287 , pp. 1824-1827
    • Hirao, A.1    Kong, Y.Y.2    Matsuoka, S.3
  • 134
    • 0030706078 scopus 로고    scopus 로고
    • UCN-01 in ovary cancer cells; effective as a single agent and in combination with cis-diaminedichloroplatinum(II) independent of p53 status
    • in A
    • in A, Yan X.J., Rosales N., et al. UCN-01 in ovary cancer cells; effective as a single agent and in combination with cis-diaminedichloroplatinum(II) independent of p53 status. Clin Cancer Res 1997, 3:2087-2097. in A.
    • (1997) Clin Cancer Res , vol.3 , pp. 2087-2097
    • in, A.1    Yan, X.J.2    Rosales, N.3
  • 135
    • 0035422203 scopus 로고    scopus 로고
    • Abrogation of the Chk1-mediated (G2) checkpoint pathway potentiates temozolominde-induced toxicity in a p53-independent manner in human glioblastoma cells
    • Hirose Y., Berger M.S., Pieper R.O. Abrogation of the Chk1-mediated (G2) checkpoint pathway potentiates temozolominde-induced toxicity in a p53-independent manner in human glioblastoma cells. Cancer Res 2001, 61:5843-5849.
    • (2001) Cancer Res , vol.61 , pp. 5843-5849
    • Hirose, Y.1    Berger, M.S.2    Pieper, R.O.3
  • 136
    • 4644318231 scopus 로고    scopus 로고
    • Potentiation of cytotoxicity of topoisomerase I poison by concurrent and sequential treatment with the checkpoint kinase inhibitor UCN-01 involves disparate mechanisms resulting in either p53-independent clonogenic suppression or p53-dependent mitotic catastrophe
    • Tse A.N., Schwarz G.K. Potentiation of cytotoxicity of topoisomerase I poison by concurrent and sequential treatment with the checkpoint kinase inhibitor UCN-01 involves disparate mechanisms resulting in either p53-independent clonogenic suppression or p53-dependent mitotic catastrophe. Cancer Res 2004, 64:6635-6644.
    • (2004) Cancer Res , vol.64 , pp. 6635-6644
    • Tse, A.N.1    Schwarz, G.K.2
  • 137
    • 0037093087 scopus 로고    scopus 로고
    • Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray
    • Han H., Bearss D.J., Browne L.W., et al. Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray. Cancer Res 2002, 62:2890-2896.
    • (2002) Cancer Res , vol.62 , pp. 2890-2896
    • Han, H.1    Bearss, D.J.2    Browne, L.W.3
  • 138
    • 0032526320 scopus 로고    scopus 로고
    • Overexpression of Rad51 protein stimulates homologous recombination and increases resistance of mammalian cells to ionizing radiation
    • Vispe S., Cazaux C., Lesca C., Defais M. Overexpression of Rad51 protein stimulates homologous recombination and increases resistance of mammalian cells to ionizing radiation. Nucleic Acids Res 1998, 26:2859-2864.
    • (1998) Nucleic Acids Res , vol.26 , pp. 2859-2864
    • Vispe, S.1    Cazaux, C.2    Lesca, C.3    Defais, M.4
  • 140
    • 0034713347 scopus 로고    scopus 로고
    • DNA repair and recombination factor Rad51 is over-expressed in human pancreatic adenocarcinoma
    • Maacke H., Jost K., Opitz S., et al. DNA repair and recombination factor Rad51 is over-expressed in human pancreatic adenocarcinoma. Oncogene 2000, 19:2791-2795.
    • (2000) Oncogene , vol.19 , pp. 2791-2795
    • Maacke, H.1    Jost, K.2    Opitz, S.3
  • 141
    • 84882447390 scopus 로고    scopus 로고
    • Olaparib (AZD2281; PARP inhibitor) and AZD7762 (CHK inhibitor) act synergistically to enhance cell death and reduce tumor growth in preclinical models. Presented at 2009 AACR Annual Meeting, Denver, USA, 18-22 April 2009, Abst 2487.
    • Zabludoff SD, Zhu AC, Deng C, et al. Olaparib (AZD2281; PARP inhibitor) and AZD7762 (CHK inhibitor) act synergistically to enhance cell death and reduce tumor growth in preclinical models. Presented at 2009 AACR Annual Meeting, Denver, USA, 18-22 April 2009, Abst 2487.
    • Zabludoff, S.D.1    Zhu, A.C.2    Deng, C.3
  • 142
    • 0034967556 scopus 로고    scopus 로고
    • ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1
    • Zhao H., Piwnica-Worms H. ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1. Mol Cell Biol 2001, 21:4129-4139.
    • (2001) Mol Cell Biol , vol.21 , pp. 4129-4139
    • Zhao, H.1    Piwnica-Worms, H.2
  • 143
    • 77950961695 scopus 로고    scopus 로고
    • Gamma;H2AX: a sensitive molecular marker of DNA damage and repair
    • Mah L.J., El-Osta A., Karagiannis T.C. gamma;H2AX: a sensitive molecular marker of DNA damage and repair. Leukemia 2010, 24:679-686.
    • (2010) Leukemia , vol.24 , pp. 679-686
    • Mah, L.J.1    El-Osta, A.2    Karagiannis, T.C.3
  • 144
    • 70450224676 scopus 로고    scopus 로고
    • H2AX: functional roles and potential applications
    • Dickey J.S., Redon C.E., Nakamura A.J., et al. H2AX: functional roles and potential applications. Chromosoma 2009, 118:683-692.
    • (2009) Chromosoma , vol.118 , pp. 683-692
    • Dickey, J.S.1    Redon, C.E.2    Nakamura, A.J.3
  • 146
    • 0032861343 scopus 로고    scopus 로고
    • Megabase chromatin domains involved in DNA double-strand breaks in vivo
    • Rogakou E.P., Boon C., Redon C., Bonner W.M. Megabase chromatin domains involved in DNA double-strand breaks in vivo. J Cell Biol 1999, 146:905-916.
    • (1999) J Cell Biol , vol.146 , pp. 905-916
    • Rogakou, E.P.1    Boon, C.2    Redon, C.3    Bonner, W.M.4
  • 147
    • 0036789173 scopus 로고    scopus 로고
    • Quantitative detection of (125)IdU-induced DNA double-strand breaks with gamma-H2AX antibody
    • Sedelnikova O.A., Rogakou E.P., Panyutin I.G., Bonner W.M. Quantitative detection of (125)IdU-induced DNA double-strand breaks with gamma-H2AX antibody. Radiat Res 2002, 158:486-492.
    • (2002) Radiat Res , vol.158 , pp. 486-492
    • Sedelnikova, O.A.1    Rogakou, E.P.2    Panyutin, I.G.3    Bonner, W.M.4
  • 148
    • 44449136965 scopus 로고    scopus 로고
    • HP1-beta mobilization promotes chromatin changes that initiate the DNA damage response
    • Ayoub N., Jeyasekharan A.D., Bernal J.A., Venkitaraman A.R. HP1-beta mobilization promotes chromatin changes that initiate the DNA damage response. Nature 2008, 453:682-686.
    • (2008) Nature , vol.453 , pp. 682-686
    • Ayoub, N.1    Jeyasekharan, A.D.2    Bernal, J.A.3    Venkitaraman, A.R.4
  • 149
    • 10844237358 scopus 로고    scopus 로고
    • Inhibition of Chk1 by CEP-3891 accelerates mitotic nuclear fragmentation in response to ionizing radiation
    • Syljuasen R.G., Sorensen C.S., Nylandsted J., et al. Inhibition of Chk1 by CEP-3891 accelerates mitotic nuclear fragmentation in response to ionizing radiation. Cancer Res 2004, 64:9035-9040.
    • (2004) Cancer Res , vol.64 , pp. 9035-9040
    • Syljuasen, R.G.1    Sorensen, C.S.2    Nylandsted, J.3
  • 150
    • 77949698506 scopus 로고    scopus 로고
    • Strategies towards more effective anticancer therapies: targeting DNA damage response pathways
    • Ashwell S. Strategies towards more effective anticancer therapies: targeting DNA damage response pathways. Expert Rev Clin Pharmacol 2010, 3:103-115.
    • (2010) Expert Rev Clin Pharmacol , vol.3 , pp. 103-115
    • Ashwell, S.1
  • 151
    • 33749626550 scopus 로고    scopus 로고
    • Phosphorylation of Chk1 by ATR is antagonized by a Chk1-regulated protein phosphatase 2A circuit
    • Leung-Pineda V., Ryan C.E., Piwnica-Worms H. Phosphorylation of Chk1 by ATR is antagonized by a Chk1-regulated protein phosphatase 2A circuit. Mol Cell Biol 2006, 26:7529-7538.
    • (2006) Mol Cell Biol , vol.26 , pp. 7529-7538
    • Leung-Pineda, V.1    Ryan, C.E.2    Piwnica-Worms, H.3
  • 152
    • 77953711939 scopus 로고    scopus 로고
    • MK-1775, a small molecule Wee1 inhibitor, enhances anti-tumor efficacy of various DNA-damaging agents, including 5-fluorouracil
    • Hirai H., Arai T., Okada M., et al. MK-1775, a small molecule Wee1 inhibitor, enhances anti-tumor efficacy of various DNA-damaging agents, including 5-fluorouracil. Cancer Biol Ther 2010, 9:514-522.
    • (2010) Cancer Biol Ther , vol.9 , pp. 514-522
    • Hirai, H.1    Arai, T.2    Okada, M.3
  • 153
    • 67649710471 scopus 로고    scopus 로고
    • Discovery of gene expression based pharmacodynamic biomarker for a p53 context-specific anti-tumor drug Wee1 inhibitor
    • Mizuarai S., Yamanaka K., Itadani H., et al. Discovery of gene expression based pharmacodynamic biomarker for a p53 context-specific anti-tumor drug Wee1 inhibitor. Mol Cancer 2009, 8:34-45.
    • (2009) Mol Cancer , vol.8 , pp. 34-45
    • Mizuarai, S.1    Yamanaka, K.2    Itadani, H.3
  • 154
    • 34250010317 scopus 로고    scopus 로고
    • Chk1 regulates the density of active replication origins during the vertebrate S phase
    • Maya-Mendoza A., Petermann E., Gillespie D.A., Caldecott K.W., Jackson D.A. Chk1 regulates the density of active replication origins during the vertebrate S phase. EMBO J 2007, 26:2719-2731.
    • (2007) EMBO J , vol.26 , pp. 2719-2731
    • Maya-Mendoza, A.1    Petermann, E.2    Gillespie, D.A.3    Caldecott, K.W.4    Jackson, D.A.5
  • 155
    • 68249126215 scopus 로고    scopus 로고
    • Taking the time to make important decisions: the checkpoint effector kinases Chk1 and Chk2 and the DNA damage response
    • Stracker T.H., Usui T., Petrini J.H. Taking the time to make important decisions: the checkpoint effector kinases Chk1 and Chk2 and the DNA damage response. DNA Repair (Amst) 2009, 8:1047-1054.
    • (2009) DNA Repair (Amst) , vol.8 , pp. 1047-1054
    • Stracker, T.H.1    Usui, T.2    Petrini, J.H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.